American Liver Foundation Taps Chicago Marathon for Liver Disease Awareness Push
Event summary
- American Liver Foundation (ALF) is an official charity partner for the 2026 Bank of America Chicago Marathon, with a 43-member team running to raise awareness and funds for liver disease.
- ALF's Liver Life Challenge endurance program leverages the marathon as a platform to educate, engage, and inspire support for liver disease prevention, research, and patient care.
- Team ALF includes runners with personal connections to liver disease, such as living donors, transplant recipients, and medical professionals.
- Funds raised will support ALF's mission to advocate for patients, fund medical research, and educate the public about liver wellness and disease prevention.
The big picture
ALF's participation in the Chicago Marathon underscores the growing trend of nonprofits using high-profile sporting events to raise funds and awareness for critical health issues. With 100 million Americans affected by liver disease, ALF's strategic focus on endurance programs and community engagement positions it as a leading voice in the fight against liver disease. The organization's ability to mobilize a diverse team of runners, including medical professionals and transplant recipients, highlights its deep roots in the liver disease community and its commitment to advancing research and patient support.
What we're watching
- Fundraising Momentum
- Whether ALF's 2026 Chicago Marathon team can meet or exceed its fundraising goals, given the personal connections and medical community involvement.
- Awareness Impact
- The pace at which ALF can translate marathon participation into sustained public awareness and engagement for liver disease prevention and research.
- Strategic Partnerships
- How ALF leverages its partnership with the Bank of America Chicago Marathon to expand its reach and impact in the liver disease community.